Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders
- PMID: 16636682
- PMCID: PMC3098558
- DOI: 10.1038/sj.mp.4001830
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders
Abstract
Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.
Figures
Similar articles
-
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.Hum Mol Genet. 2005 Jan 15;14(2):241-53. doi: 10.1093/hmg/ddi022. Epub 2004 Nov 24. Hum Mol Genet. 2005. PMID: 15563509
-
Methodological considerations for gene expression profiling of human brain.J Neurosci Methods. 2007 Jul 30;163(2):295-309. doi: 10.1016/j.jneumeth.2007.03.022. Epub 2007 Apr 8. J Neurosci Methods. 2007. PMID: 17512057 Free PMC article.
-
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.Biol Psychiatry. 2005 Mar 1;57(5):525-32. doi: 10.1016/j.biopsych.2004.11.041. Biol Psychiatry. 2005. PMID: 15737668
-
Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond.Schizophr Res. 2017 Sep;187:62-66. doi: 10.1016/j.schres.2016.10.037. Epub 2016 Nov 10. Schizophr Res. 2017. PMID: 27839913 Review.
-
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder.Mitochondrion. 2021 Mar;57:23-36. doi: 10.1016/j.mito.2020.12.002. Epub 2020 Dec 17. Mitochondrion. 2021. PMID: 33340709 Free PMC article. Review.
Cited by
-
DNA Damage in Major Psychiatric Diseases.Neurotox Res. 2016 Aug;30(2):251-67. doi: 10.1007/s12640-016-9621-9. Epub 2016 Apr 28. Neurotox Res. 2016. PMID: 27126805 Free PMC article. Review.
-
Alterations of Mitochondrial DNA Copy Number and Telomere Length With Early Adversity and Psychopathology.Biol Psychiatry. 2016 Jan 15;79(2):78-86. doi: 10.1016/j.biopsych.2014.12.025. Epub 2015 Jan 15. Biol Psychiatry. 2016. PMID: 25749099 Free PMC article.
-
Comparative Pharmacology of Risperidone and Paliperidone.Drugs R D. 2015 Jun;15(2):163-74. doi: 10.1007/s40268-015-0092-x. Drugs R D. 2015. PMID: 25943458 Free PMC article. Review.
-
Mood, stress and longevity: convergence on ANK3.Mol Psychiatry. 2016 Aug;21(8):1037-49. doi: 10.1038/mp.2016.65. Epub 2016 May 24. Mol Psychiatry. 2016. PMID: 27217151 Free PMC article.
-
Analysis of whole genome biomarker expression in blood and brain.Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):919-36. doi: 10.1002/ajmg.b.31062. Am J Med Genet B Neuropsychiatr Genet. 2010. PMID: 20127885 Free PMC article.
References
-
- Dyrskjot L. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics. Expert Rev Mol Diagn. 2003;3(5):635–647. - PubMed
-
- Ueda M, Ota J, Yamashita Y, Choi YL, Ohki R, Wada T, et al. DNA microarray analysis of stage progression mechanism in myelodys-plastic syndrome. Br J Haematol. 2003;123(2):288–296. - PubMed
-
- Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10(1):33–39. - PubMed
-
- Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. 2005;10(3):309–322. - PubMed
-
- Huffaker SJ, Ryan M, Sudhakaran P, Webster M, Goedert M, Bahn S. Large scale genechip analysis of post - mortem brains from schizophrenia and bipolar affective disorder patients. Program Number 312.16, in Abstract Viewer/ Itinerary Planner. Society for Neuroscience; Washington, DC: 2003.
